SHANGHAI--(BUSINESS WIRE)--Dec 8, 2018--Generon BioMed Holding ... announced today at the annual San Antonio Breast Cancer Symposium ...
News
- Generon Presented Positive Phase III Results From a Double-Blind, Placebo Controlled-Clinical ...
- Meridian Bioscience (VIVO) Shareholder Brown Capital Management Cut Its Stake by $5.16 Million ...
Brown Capital Management Llc decreased its stake in Meridian Bioscience Inc ... Meridian Bioscience, Inc. (NASDAQ:VIVO) has risen 11.66% since ... at San Antonio Breast Cancer Symposium – Nasdaq” published on November 14 ...
- Capital Impact Advisors Has Upped Its Matador Res Co (MTDR) Stake; Meridian Bioscience (VIVO ...
Capital Impact Advisors Llc increased Matador Res Co (MTDR) stake by 28% reported in 2018Q2 SEC filing. Capital Impact Advisors Llc acquired ...
- Arvinas Presents Preclinical Data on Protein Degrader, ARV-471, at the 2018 San Antonio Breast ...
07, 2018 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq:ARVN), a biotechnology company creating a new class of drugs based on targeted protein ...
- Is It Time to Start Worrying About the Stock Market?
Medical device maker Boston Scientific Corp. up 43 percent this year, was down 3.51 precent today and biotech firm Alexion Pharmaceuticals fell 4.49 ...